-
Oct 9, 2024 | 
msn.com | Brendan Saloner
Continue reading More for You Continue reading More for You
-
Oct 9, 2024 | 
thehill.com | Brendan Saloner
Recent headlines offer a glimmer of hope in our country’s unrelenting overdose crisis. Overdose deaths in the U.S. — which more than doubled over the last decade — made a decisive downturn in 2023. The 10 percent annual reduction in overdose deaths is especially pronounced in the Northeast and Midwest, where hurricane fentanyl first made landfall in the mid-2010s. But overdose deaths are continuing to rise in western states and among specific demographic groups, such as people over age 65.
-
Oct 9, 2024 | 
aol.com | Brendan Saloner
October 9, 2024 at 12:30 PMRecent headlines offer a glimmer of hope in our country’s unrelenting overdose crisis. Overdose deaths in the U.S. — which more than doubled over the last decade — made a decisive downturn in 2023. The 10 percent annual reduction in overdose deaths is especially pronounced in the Northeast and Midwest, where hurricane fentanyl first made landfall in the mid-2010s.
-
Oct 9, 2024 | 
malaysia.news.yahoo.com | Brendan Saloner
Brendan Saloner, opinion contributor9 October 2024 at 10:30 am·4-min readRecent headlines offer a glimmer of hope in our country’s unrelenting overdose crisis. Overdose deaths in the U.S. — which more than doubled over the last decade — made a decisive downturn in 2023. The 10 percent annual reduction in overdose deaths is especially pronounced in the Northeast and Midwest, where hurricane fentanyl first made landfall in the mid-2010s.
-
Sep 6, 2024 | 
jamanetwork.com | J. Travis Donahoe |Julie M. Donohue |Brendan Saloner
Key PointsQuestion Have disparities in medication for opioid use disorder (MOUD) treatment between individuals referred by the criminal justice system and other sources decreased?
-
May 20, 2024 | 
rand.org | Megan S. Schuler |Andrew W. Dick |Adam Gordon |Brendan Saloner
BackgroundWe examined the number and characteristics of high-volume buprenorphine prescribers and the nature of their buprenorphine prescribing from 2009 to 2018. MethodsIn this observational cohort study, IQVIA Real World retail pharmacy claims data were used to characterize trends in high-volume buprenorphine prescribers (clinicians with a mean of 30 or more active patients in every month that they were an active prescriber) during 2009–2018.
-
Apr 22, 2024 | 
jamanetwork.com | Brendan Saloner
The 2024 presidential election arrives at a moment of profound pessimism about the US addiction and overdose crisis. Overdose deaths, which were already surging before the COVID-19 pandemic, have reached new and alarming heights, claiming more than 100 000 lives in the 12 months before September 2023.1 The overdose crisis is substantially driven by the proliferation of illicitly manufactured fentanyl in the street drug supply, increasingly in combination with cocaine and methamphetamine.
-
Mar 28, 2024 | 
thehill.com | Brendan Saloner
Two decades into an opioid crisis that has claimed more than 1 million American lives, policymakers are still searching for ways to reduce overdose deaths. They would do well to focus on jails and prisons. There are 4,000 correctional facilities in the U.S., of which only a few dozen operate on-site opioid treatment programs. On any given day, there are almost 2 million incarcerated, about 15 percent of whom meet screening criteria for opioid use disorder.
-
Jul 14, 2023 | 
rand.org | Megan S. Schuler |Brendan Saloner |Adam Gordon |Andrew W. Dick
Background Buprenorphine is a key medication to treat opioid use disorder (OUD). Since its approval in 2002, buprenorphine access has grown markedly, spurred by major federal and state policy changes. This study characterizes buprenorphine treatment episodes during 2007 to 2018 with respect to payer, provider specialty, and patient demographics.
